HALO Jeffrey William Henderson sells $274K worth of shares
Apr 29, 2025, 4:34 AM
0.00%
What does HALO do
Halozyme Therapeutics, a San Diego-based biopharmaceutical company, specializes in drug delivery technology and has two proprietary products, Hylenex and XYOSTED, focusing on subcutaneous administration. Founded in 2003, it employs 373 people and partners with other firms for drug-device combinations.
Jeffrey William Henderson sold 4,497 shares of HALO on 28 April at $60.99 per share, worth a total of $274K. They now own 28,811 HALO shares, or a 14% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
